Key result
The dominant form (CG + GG) of the TP53 gene SNP rs1042522 significantly increased the risk of type 2 diabetes mellitus (OR 3.880, p<0.001).
Why the study?
The study aimed to investigate the TP53 gene SNP rs1042522 genotype and the IL-6 gene SNP rs1800795 genotype in patients with type 1 and type 2 diabetes mellitus versus controls.
Cross-Sectional (n=331)
No
The G allele of the TP53 gene SNP rs1042522 is significantly associated with an increased risk of developing type 2 diabetes mellitus in the Iranian population of Kermanshah province.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating for TP53 rs1042522 in Iranian diabetes risk; prospective studies needed before any clinical use.
Diabetes mellitus (DM) is a metabolic disorder that results from insufficient secretion or insulin resistance, or both. Insulin secretion deficiency leads to chronic hyperglycemia along with impaired metabolism of proteins, lipids, and carbohydrates. This study aimed to investigate the TP53 gene SNP (single nucleotide polymorphism) rs1042522 genotype and the interleukin-6 (IL-6) gene SNP rs1800795 genotype in DM and control groups. This study was performed on 70 patients with type 1 DM, 100 patients with type 2 DM without related complications, 66 control subjects for type 1 DM, and 95 control subjects for type 2 DM. The control groups were matched regarding age and gender and did not have a familial relationship with the patient groups. All the subjects were residents of Kermanshah, located in the western part of Iran. Polymorphisms of TP53 and IL-6 genes were determined by the polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) method. Lipid profile, fasting blood glucose, and HbA1c were measured using the ELISA and immunoturbidometric methods. The frequency of genotypes (CC, CG, GG) of the TP53 gene codon 72 in type 1 DM and its control group were significantly different (P= 0.013). Likewise, the frequency of genotypes (CC, CG, GG) of the TP53 gene codon 72 was significantly different between type 2 DM and control groups (P <0.001). The frequency of genotypes (GG, GC, CC) of G174C polymorphisms in the IL-6 gene was different between type 1 DM and control group as well as between type 2 DM and its control group, but it was not statistically significant. SNP rs1042522 genotypes in the dominant form (CG + GG vs. CC) (OR= 3.880; P < 0.001) and alleles G vs. C alleles (OR= 0.384; P < 0.001) increased the risk of type 2 DM significantly. There was no significant difference between type 1 and type 2 DM groups and respected control groups regarding the frequency of the IL-6 gene SNP rs1800795 alleles. The G allele of SNP rs1042522 encoding the TP53 gene increases the risk of developing DM in the population of the Kermanshah province, Iran.
No takes yet. Share an insight, caveat, or question.
Haghnazari et al. (2021) conducted a cross-sectional in Type 1 and Type 2 Diabetes Mellitus (n=331). TP53 gene SNP rs1042522 and IL-6 gene SNP rs1800795 variants vs. Healthy control subjects matched for age and gender was evaluated on Risk of type 2 diabetes mellitus associated with TP53 SNP rs1042522 dominant form (CG + GG vs. CC) (OR 3.880, p=< 0.001). The dominant form (CG + GG) of the TP53 gene SNP rs1042522 significantly increased the risk of type 2 diabetes mellitus (OR 3.880, p<0.001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: